Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 5;10(6):e01071.
doi: 10.14309/crj.0000000000001071. eCollection 2023 Jun.

Weight Loss Success With Repeat Intragastric Balloon Placement After Hyperinflation and Removal of the Index Balloon

Michael A Craig  1 , Carl L Kay  2 , Kendra T Stilwell  2 , John G Quiles  2
Affiliations
Case Reports

Weight Loss Success With Repeat Intragastric Balloon Placement After Hyperinflation and Removal of the Index Balloon

Michael A Craig et al. ACG Case Rep J. .

Abstract

Intragastric balloons are an increasingly common endoscopic alternative to bariatric surgery for the treatment of obesity. Hyperinflation is a rare complication that presents as acute-onset epigastric pain, nausea, vomiting, early satiety, abdominal distention or bloating, and rapid weight loss. Hyperinflation requires prompt diagnosis and removal of the balloon to prevent complications including gastric outlet obstruction or gastric perforation. We present a case of intragastric balloon hyperinflation with removal of the index device, followed by replacement with a second balloon, resulting in continued weight loss without further adverse events.

Keywords: advanced endoscopy; adverse event; bariatric surgery; obesity.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The hyperinflated intragastric balloon is vizualized within the stomach on computed tomography scan, measuring up to 12.58 cm in diameter.
Figure 2.
Figure 2.
The hyperinflated intragastic balloon is seen within the stomach during endoscopy with prominent air-fluid level.
Figure 3.
Figure 3.
Gastric erosion after removal of hyperinflated initial gastric balloon.
Figure 4.
Figure 4.
Weightloss over time with delineated events highlighted demonstrating weight loss with second initial balloon placement.
See this image and copyright information in PMC

References

    1. Moura D, Oliveira J, De Moura EGH, et al. . Effectiveness of intragastric balloon for obesity: A systematic review and meta-analysis based on randomized control trials. Surg Obes Relat Dis. 2016;12(2):420–9. - PubMed
    1. Muniraj T, Day LW, Teigen LM, et al. AGA clinical practice guidelines on intragastric balloons in the management of obesity. Gastroenterology. 2021;160(5):1799–808. - PubMed
    1. U.S. Food and Drug Administration. UPDATE: Potential Risks with Liquid-Filled Intragastric Balloons–Letter to Health Care Providers. FDA; (https://www.fda.gov/medical-devices/letters-health-care-providers/update...) (2020). Accessed January 2, 2022.
    1. Lopez-Nava G, Asokkumar R, Bautista I, Negi A. Spontaneous hyperinflation of intragastric balloon: What caused it? Endoscopy. 2020;52(05):411–2. - PubMed
    1. Quarta G, Popov VB. Intragastric balloon hyperinflation secondary to polymicrobial overgrowth associated with proton pump inhibitor use. Gastrointest Endosc. 2019;90(2):311–2. - PubMed

Publication types